
Opinion|Videos|June 24, 2024
Fusion-Guided Biopsies in Active Surveillance for Patients With Prostate Cancer
A panel of experts on prostate cancer discuss the role for fusion-guided biopsies in active surveillance for patients with prostate cancer.
Advertisement
Episodes in this series

Video content above is prompted by the following questions:
- Is there a role for fusion-guided biopsies in active surveillance for patients with prostate cancer?
- Historically what has been the standard approach for active surveillance? Which patients? How often do you monitor?
- How can fusion-guided biopsies improve surveillance strategies and inform treatment and management decisions to improve outcomes?
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
GPS-ProtecT study launched to validate Genomic Prostate Score in active surveillance
2
Permanent J code for mitomycin for intravesical solution now in effect
3
Real-World Evidence in mCSPC Management
4
Pearls & Perspectives: Sexual Health at the Intersection of Urology and Therapy, with Nicoletta Heidegger, MA, MEd, LMFT
5





















